“…Since then, lasers utilizing either a transcleral or transpupillary route have been used for reduction of IOP. Despite the advantage of IOP reduction, various cyclodestructive techniques share common complications including pain, uveitis, prolonged hypotony, haemorrhage, choroidal effusion and postoperative loss of vision . Endoscopic cyclophotocoagulation (ECP) is a more recent and Food and Drug Administration‐approved technique developed by Martin Uram to achieve the same IOP‐lowering benefits, but without such an extensive complication profile .…”